The bill amends Chapter 176O of the General Laws to enhance patient choice in the dispensing of clinician-administered drugs. It introduces a new section that defines "clinician-administered drug" and outlines the responsibilities of health benefit carriers regarding the authorization and payment for these drugs. Specifically, the bill prohibits health benefit carriers from refusing to authorize or pay for covered clinician-administered drugs, imposing additional fees or penalties on patients, or interfering with a patient's right to choose their provider or pharmacy. It also ensures that coverage cannot be limited based on the pharmacy selected by the health plan and mandates that reimbursement rates remain consistent regardless of the pharmacy used.

Additionally, the bill allows health benefit carriers to offer, but not require, the use of home infusion pharmacies or external infusion sites for administering clinician-administered drugs. This provision aims to provide flexibility in how patients receive their medications while maintaining their right to choose their healthcare provider. Overall, the legislation seeks to improve access to necessary medications and empower patients in their healthcare decisions.